- Home
- CRBG vs DGX Comparison
CRBG vs DGX Comparison
Compare CRBG & DGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRBG
- DGX
- Stock Information
- Founded
- CRBG 1957
- DGX 1967
- Country
- CRBG United States
- DGX United States
- Employees
- CRBG N/A
- DGX N/A
- Industry
- CRBG Life Insurance
- DGX Medical Specialities
- Sector
- CRBG Finance
- DGX Health Care
- Exchange
- CRBG Nasdaq
- DGX Nasdaq
- Market Cap
- CRBG 18.0B
- DGX 19.8B
- IPO Year
- CRBG 2022
- DGX 1996
- Fundamental
- Price
- CRBG $32.64
- DGX $179.43
- Analyst Decision
- CRBG Buy
- DGX Buy
- Analyst Count
- CRBG 14
- DGX 14
- Target Price
- CRBG $37.43
- DGX $185.07
- AVG Volume (30 Days)
- CRBG 2.7M
- DGX 805.2K
- Earning Date
- CRBG 07-30-2025
- DGX 07-22-2025
- Dividend Yield
- CRBG 2.95%
- DGX 1.78%
- EPS Growth
- CRBG N/A
- DGX 6.41
- EPS
- CRBG 1.17
- DGX 7.91
- Revenue
- CRBG $16,549,000,000.00
- DGX $10,158,000,000.00
- Revenue This Year
- CRBG $10.18
- DGX $10.38
- Revenue Next Year
- CRBG $7.65
- DGX $4.03
- P/E Ratio
- CRBG $27.73
- DGX $22.67
- Revenue Growth
- CRBG N/A
- DGX 9.38
- 52 Week Low
- CRBG $23.69
- DGX $135.47
- 52 Week High
- CRBG $35.36
- DGX $182.38
- Technical
- Relative Strength Index (RSI)
- CRBG 53.83
- DGX 58.65
- Support Level
- CRBG $31.71
- DGX $177.76
- Resistance Level
- CRBG $33.34
- DGX $182.38
- Average True Range (ATR)
- CRBG 0.67
- DGX 2.85
- MACD
- CRBG -0.13
- DGX 0.45
- Stochastic Oscillator
- CRBG 49.73
- DGX 73.96
About CRBG Corebridge Financial Inc.
Corebridge Financial Inc provides retirement solutions and insurance products in the United States. It offers a broad set of products and services through five segments Individual Retirement, Group Retirement, Life Insurance, Institutional Markets businesses, Corporate and Other. The majority of its revenue derives from the Individual Retirement segment.
About DGX Quest Diagnostics Incorporated
Quest Diagnostics Inc is a leading independent provider of diagnostic testing, information, and services in the us. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.